Atul Deshmukh kickstarts group with Future Leaders Award
His group hopes to use mass spectrometry-based proteomics to discover new proteins and peptides for treatment of type 2 diabetes
This November, Associate Professor Atul Deshmukh was awarded DKK 5 million as a recipient of the EFSD/Novo Nordisk Foundation Future Leaders Award. The grant covers a period of five years and is “awarded to candidates who are promising and have a track record of excellence and clear commitment to their chosen area of diabetes research”.
Atul Deshmukh says the award will help him to establish his group and support its work to discover new proteins and peptides for treatment of type 2 diabetes. Using state-of-the-art mass spectrometry-based proteomics, he hopes to discover new secreted proteins and peptides in response to physical exercise and muscle contraction.
“Despite the knowledge that type 2 diabetes can be prevented and, in many cases, reversed by exercise training, many individuals struggle to achieve the recommended amount of exercise, and type 2 diabetes prevalence continues to rise. Effective treatments that can recapitulate insulin-sensitizing aspects of exercise may hold promise as therapeutics,” he says.
For more information about the award, please visit: